Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1991 May;81(5):619–622. doi: 10.2105/ajph.81.5.619

Targeted HIV screening at a Los Angeles prenatal/family planning health center.

L J Fehrs 1, D Hill 1, P R Kerndt 1, T P Rose 1, C Henneman 1
PMCID: PMC1405093  PMID: 2014863

Abstract

In 1988, the Los Angeles County Health Department conducted a blinded human immunodeficiency virus (HIV) seroprevalence study at a public prenatal (PN) and family planning (FP) center serving mostly Hispanic women in order to determine seroprevalence and to evaluate the center's targeted HIV screening program. Four women (0.13 percent) tested positive (3/1801 PN and 1/1167 FP). Three reported no risk factors; one reported a history of syphilis since 1978. Voluntary HIV testing was selectively offered to women who reported risk factors for HIV infection. Only 14 percent (96/685) of clients offered testing chose to do it: 28 percent (14/50) of clients classified as being at highest risk of infection, and 27 percent (16/59) of women who judged themselves to have some chance of being exposed to HIV. None of the four women who tested positive by blinded testing chose testing. While few women at this center were infected with HIV, higher risk women were not persuaded to be tested through a targeted screening program. Blinded HIV seroprevalence studies provide a tool for both tracking infection in a population and evaluating screening programs.

Full text

PDF
619

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Delage G., Montplaisir S., Rémy-Prince S., Pierri E. Prevalence of hepatitis B virus infection in pregnant women in the Montreal area. CMAJ. 1986 Apr 15;134(8):897–901. [PMC free article] [PubMed] [Google Scholar]
  2. Donegan S. P., Edelin K. C., Craven D. E. HIV seroprevalence rate at the Boston City Hospital. N Engl J Med. 1988 Sep 8;319(10):653–654. doi: 10.1056/NEJM198809083191015. [DOI] [PubMed] [Google Scholar]
  3. Doskocil M., Med M., Vimmer T. Musculus rectus femoris--zacátecní slacha, její funkcní význam. Acta Chir Orthop Traumatol Cech. 1987 Apr;54(2):99–107. [PubMed] [Google Scholar]
  4. Jonas M. M., Schiff E. R., O'Sullivan M. J., de Medina M., Reddy K. R., Jeffers L. J., Fayne T., Roach K. C., Steele B. W. Failure of Centers for Disease Control criteria to identify hepatitis B infection in a large municipal obstetrical population. Ann Intern Med. 1987 Sep;107(3):335–337. doi: 10.7326/0003-4819-107-2-335. [DOI] [PubMed] [Google Scholar]
  5. Kaunitz A. M., Brewer J. L., Paryani S. G., deSausure L., Sanchez-Ramos L., Harrington P. Prenatal care and HIV screening. JAMA. 1987 Nov 20;258(19):2693–2694. [PubMed] [Google Scholar]
  6. Krasinski K., Borkowsky W., Bebenroth D., Moore T. Failure of voluntary testing for human immunodeficiency virus to identify infected parturient women in a high-risk population. N Engl J Med. 1988 Jan 21;318(3):185–185. doi: 10.1056/nejm198801213180313. [DOI] [PubMed] [Google Scholar]
  7. Kumar M. L., Dawson N. V., McCullough A. J., Radivoyevitch M., King K. C., Hertz R., Kiefer H., Hampson M., Cassidy R., Tavill A. S. Should all pregnant women be screened for hepatitis B? Ann Intern Med. 1987 Sep;107(3):273–277. doi: 10.7326/0003-4819-107-2-273. [DOI] [PubMed] [Google Scholar]
  8. Landesman S., Minkoff H., Holman S., McCalla S., Sijin O. Serosurvey of human immunodeficiency virus infection in parturients. Implications for human immunodeficiency virus testing programs of pregnant women. JAMA. 1987 Nov 20;258(19):2701–2703. [PubMed] [Google Scholar]
  9. Malecki J. M., Guarin O., Hulbert A., Brumback C. L. Prevalence of hepatitis B surface antigen among women receiving prenatal care at the Palm Beach County Health Department. Am J Obstet Gynecol. 1986 Mar;154(3):625–626. doi: 10.1016/0002-9378(86)90615-0. [DOI] [PubMed] [Google Scholar]
  10. Novick L. F., Berns D., Stricof R., Stevens R., Pass K., Wethers J. HIV seroprevalence in newborns in New York State. JAMA. 1989 Mar 24;261(12):1745–1750. [PubMed] [Google Scholar]
  11. Pappaioanou M., Dondero T. J., Jr, Petersen L. R., Onorato I. M., Sanchez C. D., Curran J. W. The family of HIV seroprevalence surveys: objectives, methods, and uses of sentinel surveillance for HIV in the United States. Public Health Rep. 1990 Mar-Apr;105(2):113–119. [PMC free article] [PubMed] [Google Scholar]
  12. Rhame F. S., Maki D. G. The case for wider use of testing for HIV infection. N Engl J Med. 1989 May 11;320(19):1248–1254. doi: 10.1056/NEJM198905113201905. [DOI] [PubMed] [Google Scholar]
  13. Schwartz R. M., Maynard E. C. Hospital policy, practice re HIV testing for pregnant women and newborns. Am J Public Health. 1990 Oct;80(10):1276–1276. doi: 10.2105/ajph.80.10.1276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wetzel A. M., Kirz D. S. Routine hepatitis screening in adolescent pregnancies: is it cost effective? Am J Obstet Gynecol. 1987 Jan;156(1):166–169. doi: 10.1016/0002-9378(87)90230-4. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES